small molecule

TECFIDERA

DIMETHYL FUMARATE

Loss of exclusivityNovember 2035latest FDA-listed patent expiry
CompanyBiogenView the full company profile on CliffBio

Drug detail

Brand nameTECFIDERA
Active ingredientDIMETHYL FUMARATE
Strength120MG
Dosage formCAPSULE, DELAYED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalMarch 2013
Marketing statusRX

Listed patents

PatentExpiresType
11246850November 2035use U-1384
10959972November 2035use U-1384
11129806November 2035use U-1384
11007166November 2035use U-1384
11007167November 2035use U-1384
10391160March 2035use U-3148
10994003March 2035use U-3148
10555993March 2035use U-3148
8399514February 2028use U-1384

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

TECFIDERA patent cliff — loss of exclusivity November 2035 | CliffBio